Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues

Yan Xing, Chaojun Wang, Jie Wu, Yan Xing, Chaojun Wang, Jie Wu

Abstract

Geminin is a protein involved in cell cycle progression. We aimed to evaluate the diagnostic value of geminin expression in cervical intraepithelial neoplasm (CIN).The expression of geminin, p16, and Ki67 was examined in 95 samples, including CIN1 (n = 45), CIN2/3 (n = 40), and normal cervical tissues (n = 10) by immunohistochemistry. The correlation between geminin or p16 expression and human papillomavirus (HPV) status was also evaluated.Geminin expression was negative in all normal tissues and expressed in 13.3% of CIN1 and 90.0% of CIN2/3. P16 expression was demonstrated in 24.4% of CIN1 and 87.5% of CIN2/3. The corresponding Ki67 expression was 35.6% and 95.0%. The specificity of geminin for differentiating between CIN1 and CIN2/3 was 86.7%, while for p16 and Ki67 the corresponding values were 75.6% and 64.4%. The sensitivity of geminin, p16, and Ki67 was 90.0%, 87.5%, and 95.0%, respectively. The positive predictive value (PPV) and accuracy of geminin were higher than p16 and Ki67. In addition, geminin expression showed a weak correlation with HPV status, but there was no association between p16 expression and HPV status.These results suggested that geminin had a high degree of sensitivity and specificity in determining CIN2/3. In addition to p16 and Ki67, geminin might be used as a new biomarker to distinguish between CIN1 and CIN2/3.

Conflict of interest statement

The author(s) declared no conflicts of interest with respect to the authorship and/or publication of this article.

Figures

Figure 1
Figure 1
Representative immunohistochemical images of geminin (A, D, and G, ×100), p16 (B, ×100, E and H, ×200), and Ki67 (C, ×100, F and I, ×200) expression in normal tissues, CIN1, and CIN2/3. All pictures were taken at original magnification.

References

    1. Martin CM, O’Leary JJ, Phil D. Histology of cervical intraepithelial neoplasia and the role of biomarkers. Best Pract Res Clin Obstet gynaecol 2011;25:605–15.
    1. Castle PE, Schiffman M, Wheeler CM, et al. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 2009;113:18–25.
    1. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425–34.
    1. Lobato S, Tafuri A, Fernandes PÁ, et al. Minichromosome maintenance 7 protein is a reliable biological marker for human cervical progressive disease. J gynecol Oncol 2012;23:11–5.
    1. Safaeian M, Schiffman M, Gage J, et al. Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Res 2009;69:3262–6.
    1. Wright TC, Stoler MH, Behrens CM, et al. Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 2015;136:189–97.
    1. Nogueira MC, Guedes Neto Ede P, Rosa MW, et al. Immunohistochemical expression of p16 and p53 in vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva. Pathol Oncol Res 2006;12:153–7.
    1. Léonard B, Kridelka F, Delbecque K, et al. A clinical and pathological overview of vulvar condyloma acuminatum, intraepithelial neoplasia, and squamous cell carcinoma. Biomed Res Int 2014;2014:480573.
    1. Sari Aslani F, Safaei A, Pourjabali M, et al. Evaluation of Ki67, p16 and CK17 markers in differentiating cervical intraepithelial neoplasia and benign lesions. Iran J Med Sci 2013;38:15–21.
    1. McCluggage WG. Premalignant lesions of the lower female genital tract: cervix, vagina and vulva. Pathology 2013;45:214–28.
    1. Kushwaha PP, Rapalli KC, Kumar S. Geminin a multi task protein involved in cancer pathophysiology and developmental process: a review. Biochimie 2016;131:115–27.
    1. Guo J, Sun N. Cell cycle regulator geminin is dispensable for the proliferation of vascular smooth muscle cells. Sci China Life Sci 2013;56:731–8.
    1. Yagi T, Inoue N, Yanai N, et al. Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers. Breast Cancer 2016;23:224–30.
    1. Shomori K, Nishihara K, Tamura T, et al. Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance. Gastric Cancer 2010;13:177–85.
    1. Haruki T, Shomori K, Hamamoto Y, et al. Geminin expression in small lung adenocarcinomas: implication of prognostic significance. Lung Cancer 2011;71:356–62.
    1. Zhu W, DePamphilis ML. Selective killing of cancer cells by suppression of geminin activity. Cancer Res 2009;69:4870–7.
    1. Martin CM, Astbury K, McEvoy L, et al. Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy. Methods Mol Biol 2009;511:333–59.
    1. Lorenzato M, Caudroy S, Bronner C, et al. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum Pathol 2005;36:1101–7.
    1. Hariri J, Oster A. The negative predictive value of p16INK4a to assess the outcome of cervical intraepithelial neoplasia 1 in the uterine cervix. Int J Gynecol Pathol 2007;26:223–8.
    1. Cones-Zamora P, Domenech-Peris A, Orantes-Casado FJ, et al. Effect of human papillomavirus on cell cycle-related protein P16, Ki-67, Cyclin D1, P53 and ProEx C in precursor lesion of cervical cancinoma. Am J Clin Pathol 2009;132:378–90.
    1. Abate E, Aseffa A, El-Tayeb M, et al. Genotyping of human papillomavirus in paraffin embedded cervical tissue samples from women in Ethiopia and the Sudan. J Med Virol 2013;85:282–7.
    1. Zhang L, Bi Q, Deng H, et al. Human papillomavirus infections among women with cervical lesions andcervical cancer in Eastern China: genotype-specific prevalence and attribution. BMC Infect Dis 2017;17:107.
    1. Zhang G, Lang J, Shen K, et al. High-risk human papillomavirus infection clearance following conization among patients with cervicalintraepithelial neoplasm grade 3 aged at least 45 years. Int J Gynaecol Obstet 2017;136:47–52.
    1. Galmiche L, Coste-Burel M, Lopes P, et al. The expression of p16 is not correlated with HPV status in CINI. Histopathology 2006;48:767.
    1. Wang L, Li J, Hou J, et al. P53 expression but not p16(INK4A) correlates with human papillomavirus-associated esophageal squamous cell carcinoma in Kazakh population. Infect Agents Cancer 2016;11:19.
    1. Liu SZ, Zandberg DP, Schumaker LM, et al. Correlation of p16 expression and HPV type with survival in oropharyngeal squamous cell cancer. Oral Oncol 2015;51:862–9.
    1. Syrjaenen K. Geographic origin is a significant determinant of human papillomavirus prevalence in oesophageal squamous cell carcinoma: systematic review and meta-analysis. Scand J Infect Dis 2013;45:1–8.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever